Literature DB >> 32265589

The impact of athrosclerosis on cognition and disability in multiple sclerosis patients: the ATHUS score.

A V Valavanis1,2, E Tsitsipa3, S Intzes4, E Psoma5, T Tegos2.   

Abstract

AIM: Atherosclerosis of the large arteries of the neck could be related to the cognitive and motor deficit. We investigated if the atherosclerosis of common carotid and femoral arteries in patients with multiple sclerosis (MS) is directly linked with a disability and has an inverse relationship with cognitive performance.
METHODS: We enrolled, in this prospective study, a random sample of 105 patients with MS and 22 healthy controls. All participants received a comprehensive neuropsychological assessment. The physical disability was quantified with the Expanded Disability Status Scale (EDSS). We utilized ultrasound of the carotid and femoral arteries to evaluate the degree of stenosis and intima-media thickness (IMT). We created a novice ultrasound index of atherosclerosis (ATHUS score) based on the arterial stenosis and the IMT of the carotid and femoral arteries. We then compared the results of the psychometric assessment and EDSS with the ATHUS score.
RESULTS: The analysis demonstrated that higher cognitive function is correlated with lower values of ATHUS score (p =0.01). Also, there was a direct correlation between the ATHUS score and EDSS (p =0.001).
CONCLUSION: Our results suggest that the degree of atherosclerosis, as calculated by the ATHUS score, is directly related to low cognitive score and higher sensory and motor disability. HIPPOKRATIA 2019, 23(2): 81-86. Copyright 2019, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  ATHUS score; Multiple sclerosis; atherosclerosis; cognition

Year:  2019        PMID: 32265589      PMCID: PMC7127921     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  33 in total

1.  The California Verbal Learning Test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms.

Authors:  Steven Paul Woods; Dean C Delis; J Cobb Scott; Joel H Kramer; James A Holdnack
Journal:  Arch Clin Neuropsychol       Date:  2006-07-14       Impact factor: 2.813

2.  A normative study of the trail making test A and B in Greek adults.

Authors:  I Zalonis; E Kararizou; N I Triantafyllou; E Kapaki; S Papageorgiou; P Sgouropoulos; D Vassilopoulos
Journal:  Clin Neuropsychol       Date:  2007-11-01       Impact factor: 3.535

3.  Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis.

Authors:  Christos Krogias; Ioannis Christou; Georgios Tsivgoulis; Ioanna Koutroulou; Christoph Schroeder; Chrissoula Lantinioti; Daniel Richter; Theodoros Karapanayiotides; Aiden Haghikia; Ralf Gold; Konstantinos Voumvourakis
Journal:  J Neuroimaging       Date:  2019-04-16       Impact factor: 2.486

4.  Subclinical atherosclerosis and subsequent cognitive function.

Authors:  Heidi C Rossetti; Myron Weiner; Linda S Hynan; C Munro Cullum; Amit Khera; Laura H Lacritz
Journal:  Atherosclerosis       Date:  2015-04-30       Impact factor: 5.162

5.  Validity of the California Verbal Learning Test-II in multiple sclerosis.

Authors:  Shane Stegen; Igor Stepanov; Diane Cookfair; Eben Schwartz; David Hojnacki; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Clin Neuropsychol       Date:  2009-11-26       Impact factor: 3.535

6.  Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study.

Authors:  E B Mathiesen; K Waterloo; O Joakimsen; S J Bakke; E A Jacobsen; K H Bønaa
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

7.  Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.

Authors:  Anand J C Eijlers; Quinten van Geest; Iris Dekker; Martijn D Steenwijk; Kim A Meijer; Hanneke E Hulst; Frederik Barkhof; Bernard M J Uitdehaag; Menno M Schoonheim; Jeroen J G Geurts
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

8.  Cognitive dysfunction in multiple sclerosis.

Authors:  Joana Guimarães; Maria José Sá
Journal:  Front Neurol       Date:  2012-05-24       Impact factor: 4.003

9.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

10.  Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Authors:  João J Cerqueira; D Alastair S Compston; Ruth Geraldes; Mario M Rosa; Klaus Schmierer; Alan Thompson; Michela Tinelli; Jacqueline Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-04       Impact factor: 10.154

View more
  1 in total

1.  Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.

Authors:  Angela Dziedzic; Elzbieta Miller; Michal Bijak; Lukasz Przyslo; Joanna Saluk-Bijak
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.